ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityActive in the last 2 years

Xiang Zhou

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5127724758. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

DPP4 suppresses pancreatic cancer growth by enhancing ferroptosis sensitivity through stabilization of ACSL4. Co-author DOI 10.1016/j.cellsig.2026.112446 ↗
Bulk anda single-cell transcriptome profiling reveals the molecular characteristics of T cell-mediated tumor killing in pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2024.e27216 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gang Chen · 1 shared paper, 2026 · strength 0.36
- Paper DPP4 suppresses pancreatic cancer growth by enhancing ferroptosis sensitivity through stabilization of ACSL4. DOI 10.1016/j.cellsig.2026.112446 ↗
Lingming Kong · 1 shared paper, 2026 · strength 0.36
- Paper DPP4 suppresses pancreatic cancer growth by enhancing ferroptosis sensitivity through stabilization of ACSL4. DOI 10.1016/j.cellsig.2026.112446 ↗
Yinwei Dai · 1 shared paper, 2024 · strength 0.26
- Paper Bulk anda single-cell transcriptome profiling reveals the molecular characteristics of T cell-mediated tumor killing in… DOI 10.1016/j.heliyon.2024.e27216 ↗
Wei‐Ming Wang · 1 shared paper, 2024 · strength 0.26
- Paper Bulk anda single-cell transcriptome profiling reveals the molecular characteristics of T cell-mediated tumor killing in… DOI 10.1016/j.heliyon.2024.e27216 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.